| 000 | 00974 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512073443.0 | ||
| 264 | 0 | _c19870423 | |
| 008 | 198704s 0 0 eng d | ||
| 022 | _a1784-3286 | ||
| 024 | 7 |
_a10.1080/22953337.1986.11719174 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarvengt, C | |
| 245 | 0 | 0 |
_aDrugs recently released in Belgium. Digoxin antibodies, alpha-2b interferon, mesalazine. _h[electronic resource] |
| 260 |
_bActa clinica Belgica _c1986 |
||
| 300 |
_a357-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAminosalicylic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aDigoxin _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon Type I _xtherapeutic use |
| 650 | 0 | 4 | _aMesalamine |
| 773 | 0 |
_tActa clinica Belgica _gvol. 41 _gno. 5 _gp. 357-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/22953337.1986.11719174 _zAvailable from publisher's website |
| 999 |
_c3831132 _d3831132 |
||